2016 - Current vs past use of NSAIDs was linked to increased risk for first HF hospitalization; risk varied by drug.
- Published in:
- ACP Journal Club, 2017, v. 166, n. 4, p. 1
- By:
- Publication type:
- Article
Works matching IS 10568751 AND DT 2017 AND VI 166 AND IP 4
Results: 10
1
2
2016 - Review: Long-term dual-antiplatelet therapy (DAPT) after PCI is no better than short-term DAPT, even with diabetes.
- Published in:
- ACP Journal Club, 2017, v. 166, n. 4, p. 1
- By:
- Publication type:
- Article
3
2016 - In left main CAD, PCI with everolimus-eluting stents was noninferior to CABG for death, MI, or stroke at 3 years.
- Published in:
- ACP Journal Club, 2017, v. 166, n. 4, p. 1
- By:
- Publication type:
- Article
4
2016 - Guideline: A hemoglobin threshold of 7 to 8 g/dL is recommended for hemodynamically stable hospitalized patients.
- Published in:
- ACP Journal Club, 2017, v. 166, n. 4, p. 1
- By:
- Publication type:
- Article
5
2016 - Pooled RCTs: In sepsis, continuous (vs intermittent) antibiotic infusion reduced hospital mortality.
- Published in:
- ACP Journal Club, 2017, v. 166, n. 4, p. 1
- By:
- Publication type:
- Article
6
2017 - In uncomplicated, left-sided acute diverticulitis, observation did not differ from antibiotics for recovery.
- Published in:
- ACP Journal Club, 2017, v. 166, n. 4, p. 1
- By:
- Publication type:
- Article
7
2016 - In stable COPD with moderate desaturation, long-term supplemental oxygen did not reduce deaths or hospitalizations.
- Published in:
- ACP Journal Club, 2017, v. 166, n. 4, p. 1
- By:
- Publication type:
- Article
8
2017 - Guideline: An expert panel found that calcium intake is safe from a cardiovascular perspective.
- Published in:
- ACP Journal Club, 2017, v. 166, n. 4, p. 1
- By:
- Publication type:
- Article
9
2016 - In left main CAD, CABG reduced major adverse cardiac or cerebrovascular events at 5 years compared with PCI.
- Published in:
- ACP Journal Club, 2017, v. 166, n. 4, p. 1
- By:
- Publication type:
- Article
10
2017 - Guideline: In acute gout, steroids, NSAIDs, or low-dose colchicine are recommended; lifestyle changes are not supported.
- Published in:
- ACP Journal Club, 2017, v. 166, n. 4, p. 1
- By:
- Publication type:
- Article